Cholecystokinin B-type receptor signaling is involved in human pancreatic cancer cell growth

Neuropeptides

Volumn 31, Issue 6, 1997, Pages 573-583

  Kaufmann, R ^a   Schafberg, H ^a   Rudroff, C ^a   Henklein, P ^b   Nowak, G ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLECYSTOKININ B RECEPTOR; CHOLECYSTOKININ OCTAPEPTIDE;

ARTICLE; CANCER GROWTH; CELL PROLIFERATION; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN TISSUE; PANCREAS CANCER; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

AGOUTI PACA;

EID: 0031456809     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0143-4179(97)90003-2     Document Type: Article

References (38)

1. Vanderhaeghen J J, Lotsrla F, De Mey J, Gilles C. Immunhistochemical location of cholecystokinin- and gastrin-like peptides in the brain and hypophysis of the rat. Proc Natl Acad Sci USA 1980; 77: 1190-1194.
2. Moran T H, Robinson P H, Goldrich M S, McHugh P R. Two brain cholecystokinin receptors: implication for behavioral actions. Brain Res 1986; 362: 175-179.
3. Bitar K N, Makhlouf G M. Receptors on smooth muscle cells: characterization by contraction and specific antagonists. Am J Physiol 1982; 242: G400-G407.
4. Yoder D G, Moody T W. High affinity binding of cholecystokinin to small cell lung cancer cells. Peptides 1987; 8: 103-107
5. Lignon M-F, Bernad N, Martinez J. Pharmacological characterization of type B cholecystokinin binding sites on the human jurkat T lymphocyte cell line. Mol Pharmacol 1991; 39: 615-620.
6. 2+ concentration in GH3, a rat anterior pituitary cell line. Jpn J Pharmacol 1991; 55: P115.
7. 6 cells. Binding studies and measurement of intracellular calcium mobilization. Brain Res 1994; 639: 109-114.
8. Smith J P, Solomon T E, Bagheri S, Kramer S. Cholecystokinin stimulates growth of human pancreatic adenocarcinoma SW-1990. Dig Dis Sci 1990; 35: 1377-1384.
9. Smith J P, Kramer S, Solomon T E. Cholecystokinin stimulates growth of six human pancreatic cancer cell lines in serum free medium. Regul Pept 1991; 32: 341-349.
10. Smith J P, Rickabaugh C A, McLaughlin P J, Zagon I S. CCK receptors and PANC-1 human pancreatic cancer cells. Am J Physiol 1993; 265: G149-G155.
11. Smith J P, Guozhen L, Soundarajan V, McLaughlin P J, Zagon I S. Identification and characterization of CCK-B/gastrin receptors in human pancreatic cancer cell lines. Am J Physiol 1994; 266: R277-R283.
12. 2. Pharmazie 1987; 42: 413-414.
13. Lin C W, Shiosaki K, Miller T R et al. Characterization of two novel cholecystokinin tetrapeptide (30-33) analogues, A-71623 and A-70874, that exhibit high potency and selectivity for cholecystokinin-A receptors. Mol Pharmacol 1990; 39: 346-351.
14. Charpentier B, Durieux C, Pelaprat D et al. Enzyme-resistant CCK analogs with high affinities for central receptors. Peptides 1988; 9: 835-841.
15. i mobilization. Mol Neuropharmacol 1993; 3: 147-151.
16. Lowry O H, Rosebrough N J, Farr A L, Randall R J. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193: 265-275.
17. Munson P J, Rodbard D. LIGAND: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem 1980; 107: 220-239.
18. Tsien R Y. Fluorescence probes of cell signaling. Annu Rev Neurosci 1989; 12: 227-253.
19. Bradford M M. A refined and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254.
20. Krüger H, Schröder W, Buchner K, Hucho F. Protein kinase C inhibition by calmodulin and its fragments. J Protein Chem 1990; 9: 467-473.
21. Alexander D R, Cantrell D A. Kinases and phosphatases in T-cell activation. Immunol Today 1989; 10: 200-205.
22. Huang K P. The mechanism of protein kinase C activation. Trends Neurosci 1989; 12: 425-432.
23. Lotti V J, Chang R S L. A new potent and selective non-peptide gastrin antagonist and brain cholecystokinin receptor (CCK-B) ligand: L-365,260. Eur J Pharmacol 1989; 162: 273-280.
24. Bock M G, Digardo R M, Evans B E et al. Benzodiazepine gastrin and cholecystokinin receptor ligands: L-353,260. J Med Chem 1989; 32: 13-16.
25. Jensen R T, Qian J-M, Lin J-T, Mantey S A, Pisegna J R, Wank S A. Distinguishing multiple CCK receptor subtypes. Ann N Y Acad Sci 1994; 713: 88-106.
26. Hughes J, Boden P, Costall B et al. Development of a class of selective cholecystokinin B type receptor antagonists having potent anxiolytic activity. Proc Natl Acad Sci USA 1990; 87: 6728-6732.
27. Pisegna J R, De Weerth A, Huppi K, Wank A S. Molecular cloning of the human brain and gastric cholecystokinin receptor: structure, functional expression and chromosomal localization. Biochem Biophys Res Commun 1992; 189: 296-303.
28. Wank S A, Pisegna J R, De Weerth A. Brain and gastrointestinal cholecystokinin receptor family: structure and functional expression. Proc Natl Acad Sci USA 1992; 89: 8691-8695.
29. Kopin A S, Lee Y-M, McBride E W et al. Expression cloning and characterization of the canine parietal cell gastrin receptor. Proc Natl Acad Sci USA 1992; 89: 3605-3609.
30. Nakata H, Matsui T, Ito M et al. Cloning and characterization of gastrin receptor from ECL carcinoid tumor of Mastomys natalensis. Biochem Biophys Res Commun 1992; 187: 1151-1157.
31. Menozzi B, Gardner J D, Maton P N. Properties of receptors for gastrin on gastric smooth muscle cells. Am J Physiol 1989; 257: G73-G79.
32. 6 cells. Binding studies and measurement of intracellular calcium mobilization. Brain Res 1994; 639: 109-114.
33. 2+ mobilization in a pituitary cell line. Eur J Pharmacol 1992; 221: 99-105.
34. 2+ concentration in the human JURKAT T lymphocyte cell line. Eur J Pharmacol 1993; 245: 241-246.
35. 2+ concentration in cultured striatal neurons. Neuropeptides 1991; 18: 115-119.
36. Staley J, Fiskum G, Moody T W. Cholecystokinin elevates cytosolic calcium in small lung cancer cells. Biochem Biophys Res Commun 1989; 163: 605-610.
37. Woll P J, Rozengurt E. Multiple neuropeptides mobilise calcium in small cell lung cancer: effects of vasopressin, bradykinin, cholecystokinin, galanin and neurotensin. Biochem Biophys Res Commun 1989; 164: 66-73.
38. Nishizuka Y The role of protein kinase C in cell surface signal transduction and tumor promoting. Nature 1984; 308: 693-697.